
Brain Sciences, Год журнала: 2025, Номер 15(6), С. 547 - 547
Опубликована: Май 23, 2025
Background: Borderline Personality Disorder (BPD) is a severe psychiatric condition characterized by pervasive emotional dysregulation, impulsivity, and unstable interpersonal relationships. Affecting over 1% of the general population, BPD carries significant morbidity, frequent hospitalizations, an increased risk suicide. Although specialized psychotherapeutic approaches have shown efficacy, their impact often constrained availability, lengthy treatment durations, moderate effect sizes, high dropout rates. Pharmacological treatments for remain inadequate are usually accompanied adverse side effects. Objective: This narrative review seeks to explore potential transcranial direct current stimulation (tDCS) as safe, cost-effective, accessible neuromodulation intervention aimed at alleviating core symptoms—namely, dysregulation impulsivity—while also addressing common comorbidities opportunities integration with existing therapeutic modalities. Methods: We conducted literature synthesis in accordance SANRA (Scale Assessment Narrative Review Articles) guidelines. A PubMed/MEDLINE search was performed using keywords related BPD, identifying five published randomized controlled trials on topic. To provide broader perspective, we included studies from fields examining mechanisms action, safety tolerability, cost-effectiveness, parameters, clinical outcomes relevant BPD. Results: Conventional tDCS protocols—typically involving 1–2 mA currents 20–30 min—have demonstrated excellent profile, resulting only minimal transient effects without any overdose or misuse, which key advantage populations suicidality. With moderately priced devices feasibility home-based administration, provides substantially more affordable alternative both long-term pharmacotherapy intensive psychotherapy. Neurobiologically, modulates excitability dorsolateral ventrolateral prefrontal cortex enhances fronto-limbic connectivity, thereby strengthening top-down regulatory control emotion behavior. Pilot report sizes improvements regulation, inhibitory control, rejection sensitivity, along ancillary gains executive functioning reductions depressive substance-use symptoms when stimulating left cortex. Conclusions: emerges safe scalable adjunctive leveraging targeted address features like depression. However, variability protocols scarcity well-powered underscore pressing need standardized methodologies, longer-term follow-up, individualized strategies establish enduring benefits.
Язык: Английский